Hosted on MSN7h
Piper Sandler Downgrades Intra-Cellular Therapies (ITCI)
Fintel reports that on January 14, 2025, Piper Sandler downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...
Fox Business on MSN17h
Market risks are more about higher rates than growth weakness: Michael Kantrowitz
Piper Sandler chief investment strategist Michael Kantrowitz reveals what 'better' economic data says about the state of the U.S. economy on 'Making Money.' ...
bovnews23h
Douglas Emmett Inc (DEI) Stock Posted a Gross Margin of 23.71% Over the Past Year: Is This Justifiable?
Douglas Emmett Inc (DEI) stock saw a modest uptick, ending the day at $16.69 which represents a slight increase of $0.53 or 3.28% from the prior close of $16.16. The stock opened at $16.17 and touched ...